Variational AI
-
Technology & Infrastructure · Models & LLMs Rakovina Therapeutics Strengthens AI-Driven Cancer Drug Discovery Partnership with Variational AI
Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company pioneering DNA-damage response therapies, has reaffirmed its strategic partnership with Variational AI. The announcement follows Variational AI’s successful $5.5 million oversubscribed financing round, led… -
Business & Markets · Startups Variational AI Announces Oversubscribed $5.5M Financing to Launch Foundation Model for Small Molecule Drug Discovery
The AI economy, every weekday morning
The daily briefing plus the weekly Scale-ups to watch edition. Free, no spam, unsubscribe any time.